Today

Agents

Chat

Arena

Discover

More

App

Sutro Biopharma Q2 Revenue USD 9.839 Million Vs. IBES Estimate USD 13 Million - STRO News | Rallies

Sutro Biopharma Q2 Revenue USD 9.839 Million Vs. IBES Estimate USD 13 Million

STRO•2026-08-12

Second-quarter results

Aug. 12 (Reuters) - Sutro Biopharma Q2 operating income was USD -29.888 million.

Q2 net income was USD -38.533 million
Q2 operating expenses were USD 39.727 million

Related News

Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates

XLO•2026-08-12

PolyPid Q2 FY26 net loss narrows 22% to $7.8 million

PYPD•2026-08-12

Nebius beats quarterly revenue estimates as AI demand fuels growth

•

2026-08-12

Brief-Amcon Distributing Company Announces Dual Listing On NYSE Texas Exchange

DIT•2026-08-12

Firefly Aerospace Inc. <FLY.O>: B. Riley cuts target price to $50 from $60

FLY•2026-08-12